The Role of Antimicrobial Peptides in Preventing Multidrug-Resistant Bacterial Infections and Biofilm Formation
暂无分享,去创建一个
[1] B. Bassler,et al. Quorum sensing: cell-to-cell communication in bacteria. , 2005, Annual review of cell and developmental biology.
[2] H. G. Boman,et al. Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine , 1993, Infection and immunity.
[3] Peng Li,et al. Perturbation of Lipopolysaccharide (LPS) Micelles by Sushi 3 (S3) Antimicrobial Peptide , 2004, Journal of Biological Chemistry.
[4] W. Kamysz,et al. In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH(2) on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics. , 2004, Diagnostic microbiology and infectious disease.
[5] A. Mattick,et al. Further observations on an inhibitory substance (nisin) from lactic streptococci. , 1947, Lancet.
[6] Dudley H. Williams,et al. A mass spectrometric assay for novel peptides: Application to Xenopus laevis skin secretions , 1985, Peptides.
[7] Thomas Bjarnsholt,et al. Antibiotic resistance of bacterial biofilms. , 2010, International journal of antimicrobial agents.
[8] M. Zasloff. Antimicrobial peptides of multicellular organisms , 2002, Nature.
[9] A. Marchese,et al. Activity of daptomycin on biofilms produced on a plastic support by Staphylococcus spp. , 2008, International journal of antimicrobial agents.
[10] N Woodford,et al. Vancomycin-resistant enterococci , 1993, The Lancet.
[11] B. Brandsdal,et al. Antimicrobial peptides with stability toward tryptic degradation. , 2008, Biochemistry.
[12] David L. Smith,et al. Hospitalizations and Deaths Caused by Methicillin-Resistant Staphylococcus aureus, United States, 1999–2005 , 2007, Emerging infectious diseases.
[13] A. Ramamoorthy,et al. Structure, membrane orientation, mechanism, and function of pexiganan--a highly potent antimicrobial peptide designed from magainin. , 2009, Biochimica et biophysica acta.
[14] D. Monroe. Looking for Chinks in the Armor of Bacterial Biofilms , 2007, PLoS biology.
[15] Y. Shai,et al. Conjugation of a magainin analogue with lipophilic acids controls hydrophobicity, solution assembly, and cell selectivity. , 2002, Biochemistry.
[16] G. Molle,et al. Antibacterial activity and pore-forming properties of ceratotoxins: a mechanism of action based on the barrel stave model. , 2004, Biochimica et biophysica acta.
[17] R. Hancock,et al. Salt-Resistant Alpha-Helical Cationic Antimicrobial Peptides , 1999, Antimicrobial Agents and Chemotherapy.
[18] M. V. van Hoek,et al. Antimicrobial and antibiofilm activity of cathelicidins and short, synthetic peptides against Francisella. , 2010, Biochemical and biophysical research communications.
[19] G. Reid,et al. Microbial Biofilms: Their Development and Significance for Medical Device—Related Infections , 1999, Journal of clinical pharmacology.
[20] Ashok Kumar,et al. Tumor necrosis factor-alpha induces functionally active hyaluronan-adhesive CD44 by activating sialidase through p38 mitogen-activated protein kinase in lipopolysaccharide-stimulated human monocytic cells. , 2003, The Journal of biological chemistry.
[21] B. Bonev,et al. Molecular Mechanism of Target Recognition by Subtilin, a Class I Lanthionine Antibiotic , 2007, Antimicrobial Agents and Chemotherapy.
[22] Anirban Bhunia,et al. High-resolution solution structure of a designed peptide bound to lipopolysaccharide: transferred nuclear Overhauser effects, micelle selectivity, and anti-endotoxic activity. , 2007, Biochemistry.
[23] C. Gardner,et al. Hypothermia as an indicator of the acute effects of lipopolysaccharides : Comparison with serum levels of IL1β, IL6 and TNFα , 1996 .
[24] Y. Carmeli,et al. Improved antimicrobial peptides based on acyl-lysine oligomers , 2007, Nature Biotechnology.
[25] R. Hancock,et al. Structure-based design of an indolicidin peptide analogue with increased protease stability. , 2003, Biochemistry.
[26] J. Hansen,et al. Nisin as a model food preservative. , 1994, Critical reviews in food science and nutrition.
[27] Y. Shai,et al. Mode of action of linear amphipathic alpha-helical antimicrobial peptides. , 1998, Biopolymers.
[28] K. Yamauchi,et al. Periodontitis, periodontopathic bacteria and lactoferrin , 2010, BioMetals.
[29] A. Po,et al. Ability of azlocillin and tobramycin in combination to delay or prevent resistance development in Pseudomonas aeruginosa. , 1999, The Journal of antimicrobial chemotherapy.
[30] Robert E. W. Hancock,et al. Multifunctional cationic host defence peptides and their clinical applications , 2011, Cellular and Molecular Life Sciences.
[31] Jeffrey B. Kaplan,et al. Differential Roles of Poly-N-Acetylglucosamine Surface Polysaccharide and Extracellular DNA in Staphylococcus aureus and Staphylococcus epidermidis Biofilms , 2007, Applied and Environmental Microbiology.
[32] M. Zaiou. Multifunctional antimicrobial peptides: therapeutic targets in several human diseases , 2007, Journal of Molecular Medicine.
[33] Kyung-Soo Hahm,et al. The membrane insertion of helical antimicrobial peptides from the N-terminus of Helicobacter pylori ribosomal protein L1. , 2010, Biochimica et biophysica acta.
[34] N. Khardori,et al. Biofilms in device-related infections , 1995, Journal of Industrial Microbiology.
[35] D. Hultmark,et al. Sequence and specificity of two antibacterial proteins involved in insect immunity , 1981, Nature.
[36] K. Hahm,et al. Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich α-helical model antimicrobial peptide and its diastereomeric peptides , 2010, Peptides.
[37] J. Costerton,et al. Bacterial biofilms: a common cause of persistent infections. , 1999, Science.
[38] Krishna Kumar,et al. Antimicrobial activity and protease stability of peptides containing fluorinated amino acids. , 2007, Journal of the American Chemical Society.
[39] K. Leung,et al. The effect of lactoferrin on oral bacterial attachment. , 2009, Oral microbiology and immunology.
[40] N. Strynadka,et al. Beta-lactam antibiotic resistance: a current structural perspective. , 2005, Current opinion in microbiology.
[41] B. Pradines,et al. Efflux mechanism, an attractive target to combat multidrug resistant Plasmodium falciparum and Pseudomonas aeruginosa. , 2009, Current medicinal chemistry.
[42] R. Hancock,et al. Antiendotoxin activity of cationic peptide antimicrobial agents , 1996, Infection and immunity.
[43] Samuel I. Miller,et al. Lipid A Acylation and Bacterial Resistance against Vertebrate Antimicrobial Peptides , 1998, Cell.
[44] Kyung-Soo Hahm,et al. Cell specificity, anti-inflammatory activity, and plausible bactericidal mechanism of designed Trp-rich model antimicrobial peptides. , 2009, Biochimica et biophysica acta.
[45] T. Falla,et al. Antimicrobial peptides: therapeutic potential , 2006, Expert opinion on pharmacotherapy.
[46] Sanjay Saint,et al. Guidelines for the prevention of intravascular catheter-related infections. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[47] H. Vogel,et al. Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action. , 2006, Biochimica et biophysica acta.
[48] R. Hancock,et al. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies , 2006, Nature Biotechnology.
[49] D. Cvitkovitch,et al. Quorum sensing in streptococcal biofilm formation. , 2005, Trends in microbiology.
[50] Y. Shai,et al. From “carpet” mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides , 2001, Peptides.
[51] C. Hernández-Chico,et al. The peptide antibiotic microcin B17 induces double‐strand cleavage of DNA mediated by E. coli DNA gyrase. , 1991, The EMBO journal.
[52] P. Marsh. Dental plaque: biological significance of a biofilm and community life-style. , 2005, Journal of clinical periodontology.
[53] J. Bang,et al. Antimicrobial specificity and mechanism of action of disulfide-removed linear analogs of the plant-derived Cys-rich antimicrobial peptide Ib-AMP1 , 2009, Peptides.
[54] Themis Lazaridis,et al. Antimicrobial peptides in toroidal and cylindrical pores. , 2010, Biochimica et biophysica acta.
[55] M. Ghadiri,et al. Systemic Antibacterial Activity of Novel Synthetic Cyclic Peptides , 2005, Antimicrobial Agents and Chemotherapy.
[56] D. White,et al. Microbiota of Plaque Microcosm Biofilms: Effect of Three Times Daily Sucrose Pulses in Different Simulated Oral Environments , 2007, Caries Research.
[57] N. Strynadka,et al. β-Lactam antibiotic resistance: a current structural perspective , 2005 .
[58] K. Brogden. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? , 2005, Nature Reviews Microbiology.
[59] D. Hassett,et al. Modulation of lung epithelial functions by Pseudomonas aeruginosa. , 2005, Trends in microbiology.
[60] G. Jung,et al. Epidermin: sequencing of a heterodetic tetracyclic 21-peptide amide antibiotic. , 1986, European journal of biochemistry.
[61] E. Breukink,et al. Membrane permeabilization by multivalent anti-microbial peptides. , 2009, Protein and peptide letters.
[62] M. Zasloff,et al. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[63] L. Yang,et al. Barrel-stave model or toroidal model? A case study on melittin pores. , 2001, Biophysical journal.
[64] B. Berger-Bächi,et al. Factors influencing methicillin resistance in staphylococci , 2002, Archives of Microbiology.
[65] R. Hancock,et al. Biological properties of structurally related alpha-helical cationic antimicrobial peptides. , 1999, Infection and immunity.
[66] Y. Shai,et al. Structure and orientation of the mammalian antibacterial peptide cecropin P1 within phospholipid membranes. , 1996, Journal of molecular biology.
[67] Samuel I. Miller,et al. How intracellular bacteria survive: surface modifications that promote resistance to host innate immune responses. , 1999, The Journal of infectious diseases.
[68] D. Cardo,et al. Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002 , 2007, Public health reports.
[69] Michael R. Yeaman,et al. Mechanisms of Antimicrobial Peptide Action and Resistance , 2003, Pharmacological Reviews.
[70] J. Nickel,et al. Bacterial biofilms: influence on the pathogenesis, diagnosis and treatment of urinary tract infections. , 1994, The Journal of antimicrobial chemotherapy.
[71] N. Sharon,et al. Binding of simple carbohydrates and some N-acetyllactosamine-containing oligosaccharides to Erythrina cristagalli agglutinin as followed with a fluorescent indicator ligand. , 1984, Archives of biochemistry and biophysics.
[72] P. Sankaridurg,et al. In vivo performance of melimine as an antimicrobial coating for contact lenses in models of CLARE and CLPU. , 2009, Investigative ophthalmology & visual science.
[73] B. Iglewski,et al. P. aeruginosa Biofilms in CF Infection , 2008, Clinical reviews in allergy & immunology.
[74] J. Łukasiak,et al. Efficacy of Tachyplesin III, Colistin, and Imipenem against a Multiresistant Pseudomonas aeruginosa Strain , 2007, Antimicrobial Agents and Chemotherapy.
[75] R. Hancock,et al. Biological Properties of Structurally Related α-Helical Cationic Antimicrobial Peptides , 1999, Infection and Immunity.
[76] Ralf Hoffmann,et al. Identification of crucial residues for the antibacterial activity of the proline-rich peptide, pyrrhocoricin. , 2002, European journal of biochemistry.
[77] Michael J. MacCoss,et al. Aminoglycoside antibiotics induce bacterial biofilm formation , 2005, Nature.
[78] Y. Porat,et al. Acyl-Substituted Dermaseptin S4 Derivatives with Improved Bactericidal Properties, Including on Oral Microflora , 2006, Antimicrobial Agents and Chemotherapy.
[79] I. Lasa,et al. Cloning, Nucleotide Sequencing, and Analysis of the AcrAB-TolC Efflux Pump of Enterobacter cloacae and Determination of Its Involvement in Antibiotic Resistance in a Clinical Isolate , 2007, Antimicrobial Agents and Chemotherapy.
[80] H. Dommisch,et al. The immune response of oral epithelial cells induced by single-species and complex naturally formed biofilms. , 2009, Oral microbiology and immunology.
[81] O. Kuipers,et al. An Alternative Bactericidal Mechanism of Action for Lantibiotic Peptides That Target Lipid II , 2006, Science.
[82] B. Beutler,et al. Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infections: benefits and hazards of LPS hypersensitivity. , 2008, Immunobiology.
[83] U. Seydel,et al. Lipid-mediated resistance of Gram-negative bacteria against various pore-forming antimicrobial peptides , 2005, Journal of endotoxin research.
[84] Simona Jevševar,et al. PEGylation of therapeutic proteins , 2010, Biotechnology journal.
[85] R. Proctor,et al. In vitro susceptibility of Staphylococcus aureus to thrombin-induced platelet microbicidal protein-1 (tPMP-1) is influenced by cell membrane phospholipid composition and asymmetry. , 2007, Microbiology.
[86] Paul Stoodley,et al. Evolving concepts in biofilm infections , 2009, Cellular microbiology.
[87] N. Kumar,et al. A novel cationic‐peptide coating for the prevention of microbial colonization on contact lenses , 2008, Journal of applied microbiology.
[88] C. Padilla,et al. In vitro antimicrobial effect of bacteriocin PsVP-10 in combination with chlorhexidine and triclosan against Streptococcus mutans and Streptococcus sobrinus strains. , 2009, Archives of oral biology.
[89] W. Kamysz,et al. Potential Therapeutic Role of Cationic Peptides in Three Experimental Models of Septic Shock , 2002, Antimicrobial Agents and Chemotherapy.
[90] Ashok Kumar,et al. Tumor Necrosis Factor-α Induces Functionally Active Hyaluronan-adhesive CD44 by Activating Sialidase through p38 Mitogen-activated Protein Kinase in Lipopolysaccharide-stimulated Human Monocytic Cells* , 2003, Journal of Biological Chemistry.
[91] J. Costerton,et al. Antibiotic resistance of bacteria in biofilms , 2001, The Lancet.
[92] H. Sahl,et al. Biosynthesis and biological activities of lantibiotics with unique post-translational modifications. , 1995, European journal of biochemistry.
[93] S. Lau,et al. Mechanism of antibiotic efflux in Gram-negative bacteria. , 2003, Frontiers in bioscience : a journal and virtual library.
[94] M. Phansalkar,et al. Mersacidin, a new antibiotic from Bacillus. Fermentation, isolation, purification and chemical characterization. , 1992, The Journal of antibiotics.
[95] Wei-Ting Huang,et al. Structural and DNA-binding studies on the bovine antimicrobial peptide, indolicidin: evidence for multiple conformations involved in binding to membranes and DNA , 2005, Nucleic acids research.
[96] M. Falagas,et al. Polymyxin B: similarities to and differences from colistin (polymyxin E) , 2007, Expert review of anti-infective therapy.
[97] B. Ho,et al. The Sushi peptides: structural characterization and mode of action against Gram-negative bacteria , 2008, Cellular and Molecular Life Sciences.
[98] R. Kaptein,et al. The nisin–lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics , 2004, Nature Structural &Molecular Biology.
[99] T. Campbell,et al. Antimicrobial Peptides for Plaque Control , 2009, Advances in dental research.
[100] K. Yamauchi,et al. Inhibitory Effects of Lactoferrin on Growth and Biofilm Formation of Porphyromonas gingivalis and Prevotella intermedia , 2009, Antimicrobial Agents and Chemotherapy.
[101] Bonnie L Bassler,et al. A strategy for antagonizing quorum sensing. , 2011, Molecular cell.
[102] H. Sahl,et al. Lantibiotics: mode of action, biosynthesis and bioengineering. , 2009, Current pharmaceutical biotechnology.
[103] M. Yamazaki,et al. Magainin 2-induced pore formation in the lipid membranes depends on its concentration in the membrane interface. , 2009, The journal of physical chemistry. B.
[104] H. Sahl,et al. Structural similarities of the staphylococcin-like peptide Pep-5 to the peptide antibiotic nisin , 1985, Antimicrobial Agents and Chemotherapy.
[105] S J Ludtke,et al. Membrane pores induced by magainin. , 1996, Biochemistry.
[106] Duncan Patrick McGregor,et al. Discovering and improving novel peptide therapeutics. , 2008, Current opinion in pharmacology.
[107] H. Sahl,et al. Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model. , 2004, The Journal of antimicrobial chemotherapy.
[108] H. Sahl,et al. The Lantibiotic Mersacidin Inhibits Peptidoglycan Synthesis by Targeting Lipid II , 1998, Antimicrobial Agents and Chemotherapy.
[109] Y. Shai,et al. Mode of action of linear amphipathic α-helical antimicrobial peptides , 1998 .
[110] G. Thorne,et al. Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies. , 2009, The Journal of antimicrobial chemotherapy.
[111] M. Nishida,et al. Action mechanism of tachyplesin I and effects of PEGylation. , 2007, Biochimica et biophysica acta.
[112] S. Gorman,et al. Antimicrobial Activity of Short, Synthetic Cationic Lipopeptides , 2010, Chemical biology & drug design.
[113] Pierre Nicolas,et al. Multifunctional host defense peptides: intracellular‐targeting antimicrobial peptides , 2009, The FEBS journal.
[114] H. H. Peter,et al. Duramycins B and C, two new lanthionine containing antibiotics as inhibitors of phospholipase A2. Structural revision of duramycin and cinnamycin. , 1990, The Journal of antibiotics.
[115] J. Kaplan. Therapeutic Potential of Biofilm-Dispersing Enzymes , 2009 .
[116] Seong-Cheol Park,et al. C-terminal amidation of PMAP-23: translocation to the inner membrane of Gram-negative bacteria , 2010, Amino Acids.
[117] K. Hahm,et al. Antibacterial synergism of novel antibiotic peptides with chloramphenicol. , 2004, Biochemical and biophysical research communications.
[118] A. Bayer,et al. Inhibition of intracellular macromolecular synthesis in Staphylococcus aureus by thrombin-induced platelet microbicidal proteins. , 2002, The Journal of infectious diseases.
[119] P. Marsh,et al. Dental plaque as a biofilm , 1995, Journal of Industrial Microbiology.
[120] L. Wong,et al. Oral Biofilms: Emerging Concepts in Microbial Ecology , 2010, Journal of dental research.
[121] M. Yoshinari,et al. Prevention of biofilm formation on titanium surfaces modified with conjugated molecules comprised of antimicrobial and titanium-binding peptides , 2010, Biofouling.
[122] J. Carver,et al. The solution structure and activity of caerin 1.1, an antimicrobial peptide from the Australian green tree frog, Litoria splendida. , 1997, European journal of biochemistry.
[123] R. Hancock,et al. Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation , 2008, Infection and Immunity.
[124] R. Isaacson. MBI-226. Micrologix/Fujisawa. , 2003, Current opinion in investigational drugs.
[125] L. Glaser. Bacterial cell surface polysaccharides. , 1973, Annual review of biochemistry.
[126] M. Nishida,et al. Action mechanism of PEGylated magainin 2 analogue peptide. , 2007, Biochimica et biophysica acta.
[127] T. Mogi,et al. Gramicidin S and polymyxins: the revival of cationic cyclic peptide antibiotics , 2009, Cellular and Molecular Life Sciences.
[128] S. Ludtke,et al. Characterization of antibiotic peptide pores using cryo-EM and comparison to neutron scattering. , 2009, Biophysical journal.
[129] Gianfranco Pasut,et al. PEG conjugates in clinical development or use as anticancer agents: an overview. , 2009, Advanced drug delivery reviews.
[130] Bruce A. Stanton,et al. Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway. , 2008, Pulmonary pharmacology & therapeutics.
[131] F. Veronese,et al. The Impact of PEGylation on Biological Therapies , 2012, BioDrugs.
[132] T. McIntosh,et al. Melittin-induced bilayer leakage depends on lipid material properties: evidence for toroidal pores. , 2005, Biophysical journal.
[133] S. Lovas,et al. The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding. , 2001, Biochemistry.
[134] Dong-Kuk Lee,et al. Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37. , 2003, Biochemistry.
[135] Paul Stoodley,et al. The effect of the chemical, biological, and physical environment on quorum sensing in structured microbial communities , 2006, Analytical and bioanalytical chemistry.
[136] S. Gellman,et al. Mimicry of host-defense peptides by unnatural oligomers: antimicrobial beta-peptides. , 2002, Journal of the American Chemical Society.
[137] J. Łukasiak,et al. Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection , 2006, Peptides.
[138] J. Zimmerberg,et al. Interaction of hagfish cathelicidin antimicrobial peptides with model lipid membranes , 2002, FEBS letters.
[139] W. Stamm. Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention. , 1991, The American journal of medicine.
[140] G. Duckworth,et al. Surveillance and epidemiology of MRSA bacteraemia in the UK. , 2005, The Journal of antimicrobial chemotherapy.
[141] Ayyalusamy Ramamoorthy,et al. Cholesterol reduces pardaxin's dynamics-a barrel-stave mechanism of membrane disruption investigated by solid-state NMR. , 2010, Biochimica et biophysica acta.
[142] Seong-Cheol Park,et al. Synergism of Leu-Lys rich antimicrobial peptides and chloramphenicol against bacterial cells. , 2006, Biochimica et biophysica acta.
[143] L. Kwak,et al. Roles of antimicrobial peptides such as defensins in innate and adaptive immunity , 2003, Annals of the rheumatic diseases.
[144] J W Costerton,et al. The bacterial glycocalyx in nature and disease. , 1981, Annual review of microbiology.
[145] S. Gellman,et al. Mimicry of Host-Defense Peptides by Unnatural Oligomers: Antimicrobial β-Peptides , 2002 .
[146] D. Whitcomb,et al. Human Pancreatic Digestive Enzymes , 2007, Digestive Diseases and Sciences.
[147] G. Seibert,et al. Mersacidin, a new antibiotic from Bacillus. In vitro and in vivo antibacterial activity. , 1992, The Journal of antibiotics.
[148] R. Darouiche,et al. Antimicrobial and antibiofilm efficacy of triclosan and DispersinB combination. , 2009, The Journal of antimicrobial chemotherapy.
[149] Paul Stoodley,et al. Bacterial biofilms: from the Natural environment to infectious diseases , 2004, Nature Reviews Microbiology.
[150] P. Henderson,et al. Antibiotic resistance: multidrug efflux proteins, a common transport mechanism? , 2005, Natural product reports.
[151] O. Brakstad,et al. Mechanisms of methicillin resistance in staphylococci , 1997, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[152] Mingyun Li,et al. Bacterial interactions in dental biofilm , 2011, Virulence.
[153] D. Sahal,et al. Synergy with Rifampin and Kanamycin Enhances Potency, Kill Kinetics, and Selectivity of DeNovo-Designed Antimicrobial Peptides , 2010, Antimicrobial Agents and Chemotherapy.
[154] R. D. McCormick,et al. Guidelines for the prevention of intravascular catheter-related infections. , 2002, Infection control and hospital epidemiology.
[155] C. B. Park,et al. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. , 1998, Biochemical and biophysical research communications.
[156] A. Barron,et al. Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides , 2008, Proceedings of the National Academy of Sciences.
[157] S. Barriere. Bacterial Resistance to β‐Lactams, and Its Prevention With Combination Antimicrobial Therapy , 1992, Pharmacotherapy.
[158] S. Lovas,et al. Interaction between heat shock proteins and antimicrobial peptides. , 2000, Biochemistry.
[159] Zhimin Zhou,et al. Lipid A modifications characteristic of Salmonella typhimurium are induced by NH4VO3 in Escherichia coli K12. Detection of 4-amino-4-deoxy-L-arabinose, phosphoethanolamine and palmitate. , 1999, The Journal of biological chemistry.
[160] J S Brown,et al. Oral biofilms, periodontitis and pulmonary infections. , 2007, Oral diseases.
[161] R. Cantor. Size distribution of barrel-stave aggregates of membrane peptides: influence of the bilayer lateral pressure profile. , 2002, Biophysical journal.
[162] R. Titball,et al. Proteolytic Degradation of Human Antimicrobial Peptide LL-37 by Bacillus anthracis May Contribute to Virulence , 2006, Antimicrobial Agents and Chemotherapy.
[163] U. Römling,et al. Human cathelicidin peptide LL37 inhibits both attachment capability and biofilm formation of Staphylococcus epidermidis , 2010, Letters in applied microbiology.
[164] T. Algara,et al. Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonisation models. , 2009, International journal of antimicrobial agents.
[165] C. Subbalakshmi,et al. Mechanism of antimicrobial action of indolicidin. , 1998, FEMS microbiology letters.
[166] K. Hojo,et al. Bacterial Interactions in Dental Biofilm Development , 2009, Journal of dental research.
[167] M. Gilmore,et al. Quorum sensing and DNA release in bacterial biofilms. , 2006, Current opinion in microbiology.
[168] V. Saba,et al. Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection. , 2008, The Journal of antimicrobial chemotherapy.
[169] D. Storm,et al. Polymyxin and related peptide antibiotics. , 1977, Annual review of biochemistry.
[170] D. Kovacevich,et al. Guidelines for the prevention of intravascular catheter-related infections: Centers for Disease Control and Prevention. , 2003, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.
[171] B. Han,et al. Modification of antimicrobial peptide with low molar mass poly(ethylene glycol). , 2008, Journal of biochemistry.
[172] J. Palmer. Bacterial Biofilms in Chronic Rhinosinusitis , 2006, The Annals of otology, rhinology & laryngology. Supplement.
[173] Ju Hyun Cho,et al. Buforins: histone H2A-derived antimicrobial peptides from toad stomach. , 2009, Biochimica et biophysica acta.
[174] V. Nizet,et al. ClpX Contributes to Innate Defense Peptide Resistance and Virulence Phenotypes of Bacillus anthracis , 2009, Journal of Innate Immunity.
[175] Seong-Cheol Park,et al. Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions. , 2008, Biochimica et biophysica acta.
[176] J. Rudney. Saliva and Dental Plaque , 2000, Advances in dental research.
[177] Seong-Cheol Park,et al. Antibiotic and synergistic effect of Leu-Lys rich peptide against antibiotic resistant microorganisms isolated from patients with cholelithiasis. , 2010, Biochemical and biophysical research communications.
[178] D. Matthews,et al. PROTEIN DIGESTION AND ABSORPTION , 1957 .
[179] I. Sutherland. Biofilm exopolysaccharides: a strong and sticky framework. , 2001, Microbiology.
[180] Seong-Cheol Park,et al. Investigation of toroidal pore and oligomerization by melittin using transmission electron microscopy. , 2006, Biochemical and biophysical research communications.
[181] J. Costerton,et al. Introduction to biofilm. , 1999, International journal of antimicrobial agents.
[182] J. Grant Burgess,et al. Molecular mechanisms of compounds affecting bacterial biofilm formation and dispersal , 2010, Applied Microbiology and Biotechnology.